Loading...
10 South Korea Central Nervous System Drugs Reports
Country Covered: South Korea
Study Period: 2018-2028
Major Players: Abbott Laboratories, Axogen Corporation, Medtronic, Boston Scientific Corporation, Integra LifeSciences Corporation
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Medtronic Plc, AngioDynamics, Inc., Lumenis, Teleflex Incorporated, Quanta System (El.en.)
Country Covered: South Korea
Study Period: 2019-2027
Major Players: AbbVie Inc., Eli Lilly (Dermira), Advin Health Care, Dermavant (Roivant Sciences), Brickell Biotech Inc.
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Zimmer Biomet, Anika Therapeutics, Inc., Bioventus LLC, Ferring B.V., sanofi-aventis LLC
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Eli Lilly & Co. , GlaxoSmithKline LLC , Pfizer Inc. , Novartis Pharmaceutical Corporation , Mylan Pharmaceuticals Inc.
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Bioness Inc. , Saebo Inc. , Boston Orthotics & Prosthetics , Ottobock, Ossur
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Biogen, Novartis AG, Merck KGaA, Eli Lilly and Company, Johnson & Johnson Private Limited
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Novartis AG, AbbVie Inc., Amgen Inc., Boehringer Ingelheim International GmbH, UCB S.A.
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Janssen Biotech, AbbVie, UCB, Amgen, Novartis Pharmaceuticals Corporation
Country Covered: South Korea
Study Period: 2018 - 2028
Major Players: Ironshore Pharmaceuticals Inc. , Novartis AG , Takeda Pharmaceutical Co. Ltd, Azurity Pharmaceuticals, Inc., Noven Therapeutics, LLC.